DE VOS PHARMA
Board
2 directors, last change in 2023Director (not named in the articles), permanent representative Gielen Davy
since 01-01-2016
earlier manager (not named in the articles), until 30-10-2023
listed in the 2025 annual accounts, filed on 23-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 30-10-2023
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayDe Vos Ilse
Director
Director
DGI CONSULTING BV
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- De Vos Ilse
- Director, from 15-01-2009 to date
- DGI CONSULTING BV
- Director, from 01-01-2016 to 30-10-2023
- Director (not named in the articles), since before 30-10-2023
Control
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Articles of association
deed of 30-10-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“Bestuursorgaan, algemene vergadering bepaalt aantal,duur opdracht en bevoegdheid”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Saturday of May